The Government supports the Doha Declaration on Trade-Related Aspects of Intellectual Property Rights (TRIPS) and Public Health and, within that, a country\u2019s right to use compulsory licensing, where necessary and appropriate, to achieve public health policy objectives in the case of national health emergencies. We are aware of the potential impact such initiatives may have on access to medicines, market dynamics, and innovation. We are closely following the process undertaken by Colombia and are in regular dialogue with them on this and other regulatory matters.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/632", "label" : {"_value" : "Biography information for Mr Douglas Alexander"} } , "answeringMemberConstituency" : {"_value" : "Lothian East"} , "answeringMemberPrinted" : {"_value" : "Mr Douglas Alexander"} , "dateOfAnswer" : {"_value" : "2024-10-31", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2024-10-31T11:49:59.977Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "214"} , "answeringDeptShortName" : {"_value" : "Business and Trade"} , "answeringDeptSortName" : {"_value" : "Business and Trade"} , "date" : {"_value" : "2024-10-24", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Drugs: Licensing"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Business and Trade, whether his Department supports the use of Compulsory Licences to gain access to medicines (a) generally and (b) by Columbia for access to dolutegravir.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4131", "label" : {"_value" : "Biography information for Jim Shannon"} } , "tablingMemberConstituency" : {"_value" : "Strangford"} , "tablingMemberPrinted" : [{"_value" : "Jim Shannon"} ], "uin" : "10999"} , {"_about" : "http://data.parliament.uk/resources/1736451", "AnsweringBody" : [{"_value" : "Ministry of Justice"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1736451/answer", "answerText" : {"_value" : "
The Lord Chancellor has not yet had the opportunity to discuss the courts and tribunals across England and Wales, including the backlogs that some jurisdictions face, with the Northern Ireland Justice Minister. Ministry of Justice ministers are hopeful that they will have the opportunity to discuss courts throughput with the Justice Minister soon, either bilaterally or through the Inter-Ministerial Group for Justice.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4038", "label" : {"_value" : "Biography information for Heidi Alexander"} } , "answeringMemberConstituency" : {"_value" : "Swindon South"} , "answeringMemberPrinted" : {"_value" : "Heidi Alexander"} , "dateOfAnswer" : {"_value" : "2024-10-31", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2024-10-31T14:27:29.69Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "54"} , "answeringDeptShortName" : {"_value" : "Justice"} , "answeringDeptSortName" : {"_value" : "Justice"} , "date" : {"_value" : "2024-10-23", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Courts: Northern Ireland"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Justice, what recent discussions she has had with the Justice Minister in Northern Ireland on backlogs in court cases.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4131", "label" : {"_value" : "Biography information for Jim Shannon"} } , "tablingMemberConstituency" : {"_value" : "Strangford"} , "tablingMemberPrinted" : [{"_value" : "Jim Shannon"} ], "uin" : "10725"} , {"_about" : "http://data.parliament.uk/resources/1736452", "AnsweringBody" : [{"_value" : "Department for Business and Trade"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1736452/answer", "answerText" : {"_value" : "
In recent years the Government has commissioned research covering both corporate and personal voluntary insolvency processes. In 2022 the company voluntary arrangement research report<\/a> was published and on 17 October 2024 the research findings into Individual Voluntary Arrangements (IVAs) <\/a>was published. Further research into corporate voluntary insolvency processes will be published later this year. The Government will be considering the findings of this research, and along with other evidence, may bring forward proposals for reform in due course.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4418", "label" : {"_value" : "Biography information for Justin Madders"}
}
, "answeringMemberConstituency" : {"_value" : "Ellesmere Port and Bromborough"}
, "answeringMemberPrinted" : {"_value" : "Justin Madders"}
, "dateOfAnswer" : {"_value" : "2024-10-30", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2024-10-30T16:36:30.2Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "214"}
, "answeringDeptShortName" : {"_value" : "Business and Trade"}
, "answeringDeptSortName" : {"_value" : "Business and Trade"}
, "date" : {"_value" : "2024-10-23", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Companies: Insolvency"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Business and Trade, what assessment he has made of the potential for abuse of voluntary insolvencies.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4131", "label" : {"_value" : "Biography information for Jim Shannon"}
}
, "tablingMemberConstituency" : {"_value" : "Strangford"}
, "tablingMemberPrinted" : [{"_value" : "Jim Shannon"}
], "uin" : "10726"}
, {"_about" : "http://data.parliament.uk/resources/1736453", "AnsweringBody" : [{"_value" : "Ministry of Housing, Communities and Local Government"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1736453/answer", "answerText" : {"_value" : " MHCLG Ministers and officials engage regularly with their counterparts in the devolved administrations to discuss a range of issues, including tackling homelessness.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4138", "label" : {"_value" : "Biography information for Rushanara Ali"}
}
, "answeringMemberConstituency" : {"_value" : "Bethnal Green and Stepney"}
, "answeringMemberPrinted" : {"_value" : "Rushanara Ali"}
, "dateOfAnswer" : {"_value" : "2024-10-31", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2024-10-31T14:55:14.23Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "7"}
, "answeringDeptShortName" : {"_value" : "Housing, Communities and Local Government"}
, "answeringDeptSortName" : {"_value" : "Housing, Communities and Local Government"}
, "date" : {"_value" : "2024-10-23", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Homelessness: Northern Ireland"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Housing, Communities and Local Government, what discussions her Department has had with the Department of Communities in Northern Ireland on tackling homelessness.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4131", "label" : {"_value" : "Biography information for Jim Shannon"}
}
, "tablingMemberConstituency" : {"_value" : "Strangford"}
, "tablingMemberPrinted" : [{"_value" : "Jim Shannon"}
], "uin" : "10727"}
, {"_about" : "http://data.parliament.uk/resources/1736454", "AnsweringBody" : [{"_value" : "Department for Work and Pensions"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1736454/answer", "answerText" : {"_value" : " Winter Fuel Payments will continue to be paid to pensioner households with someone receiving Pension Credit or certain other income-related benefits. They will continue to be worth £200 for eligible households, or £300 for eligible households with someone aged 80 and over.<\/p> <\/p> Entitlement to Attendance Allowance is based on the on-going need for frequent personal care and attention, or supervision to ensure personal safety, rather than on the individual\u2019s medical condition. It is paid out of general taxation and is a tax-free, non-contributory, and non-means-tested benefit so is not affected by other income or savings.<\/p> <\/p> Pensioners in receipt of Attendance Allowance and on a low-income may qualify for Pension Credit if all other eligibility criteria are met. Moreover, pensioners on low incomes and in receipt of Attendance Allowance can qualify for an additional amount in Pension Credit, providing they meet the other eligibility criteria.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4077", "label" : {"_value" : "Biography information for Emma Reynolds"}
}
, "answeringMemberConstituency" : {"_value" : "Wycombe"}
, "answeringMemberPrinted" : {"_value" : "Emma Reynolds"}
, "dateOfAnswer" : {"_value" : "2024-10-28", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2024-10-28T17:23:17.027Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "29"}
, "answeringDeptShortName" : {"_value" : "Work and Pensions"}
, "answeringDeptSortName" : {"_value" : "Work and Pensions"}
, "date" : {"_value" : "2024-10-23", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Winter Fuel Payment: Pensioners"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Work and Pensions, if she will make an assessment of the potential merits extending the eligibility for the winter fuel payment to pensioners in receipt of Attendance Allowance who suffer with medical conditions.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4131", "label" : {"_value" : "Biography information for Jim Shannon"}
}
, "tablingMemberConstituency" : {"_value" : "Strangford"}
, "tablingMemberPrinted" : [{"_value" : "Jim Shannon"}
], "uin" : "10728"}
, {"_about" : "http://data.parliament.uk/resources/1736459", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1736459/answer", "answerText" : {"_value" : " Whilst my Rt. Hon. friend, the Secretary of State for Health and Social Care has met with his counterpart in Northern Ireland to discuss various issues related to health, occupational therapy was not discussed. Health is a devolved matter for Northern Ireland.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/1506", "label" : {"_value" : "Biography information for Andrew Gwynne"}
}
, "answeringMemberConstituency" : {"_value" : "Gorton and Denton"}
, "answeringMemberPrinted" : {"_value" : "Andrew Gwynne"}
, "dateOfAnswer" : {"_value" : "2024-10-30", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2024-10-30T17:10:19.73Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2024-10-23", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Occupational Therapy: Northern Ireland"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, what discussions he has had with the Health Minister in Northern Ireland on delays in occupational therapy referrals.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4131", "label" : {"_value" : "Biography information for Jim Shannon"}
}
, "tablingMemberConstituency" : {"_value" : "Strangford"}
, "tablingMemberPrinted" : [{"_value" : "Jim Shannon"}
], "uin" : "10729"}
, {"_about" : "http://data.parliament.uk/resources/1736604", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1736604/answer", "answerText" : {"_value" : " Currently men who have symptoms that could be associated with prostate cancer may be offered a test called the Prostate Specific Antigen (PSA) test, which looks at levels of PSA in the blood in line with National Institute for Health and Care Excellence cancer recognition and referral guidance. However, due to the poor ability of PSA to predict cancer, the PSA test is not recommended as a screening tool for healthy men with no symptoms. This includes those at higher risk of prostate cancer.<\/p> This is because the high level of inaccuracy could lead to unnecessary tests that carry risks of life-changing harm, such as urinary and faecal incontinence, sexual dysfunction, as well as a smaller but serious risk of sepsis. Additionally, some prostate cancers may not produce elevated PSA levels, leading to false-negative results that provide deceptive reassurance.<\/p> Instead, men should be encouraged to know the symptoms of prostate cancer and look out for changes in their body and seek advice from a general practitioner if these changes occur.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/1506", "label" : {"_value" : "Biography information for Andrew Gwynne"}
}
, "answeringMemberConstituency" : {"_value" : "Gorton and Denton"}
, "answeringMemberPrinted" : {"_value" : "Andrew Gwynne"}
, "dateOfAnswer" : {"_value" : "2024-10-30", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2024-10-30T13:29:57.82Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2024-10-23", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Prostate Cancer: Screening"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure that men at risk of prostate cancer are able to access prostate specific antigen tests.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4131", "label" : {"_value" : "Biography information for Jim Shannon"}
}
, "tablingMemberConstituency" : {"_value" : "Strangford"}
, "tablingMemberPrinted" : [{"_value" : "Jim Shannon"}
], "uin" : "10733"}
, {"_about" : "http://data.parliament.uk/resources/1736112", "AnsweringBody" : [{"_value" : "Foreign, Commonwealth and Development Office"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1736112/answer", "answerText" : {"_value" : " The UK is a leading donor to the fight against Malaria. Our £1 billion contribution (2023-2025) to the Global Fund will distribute 86 million treated mosquito nets, provide 452,000 doses of seasonal malaria chemoprevention and treat for 18 million cases. I recently met the Gavi CEO, Sania Nishtar, and discussed our £1.65 billion investment (2021-2025) and Gavi's rollout of malaria vaccines, which will support the immunisation of more than 6 million children by the end of 2025. This is complemented by investments in UNITAID, WHO and others to strengthen health systems and improve access to malaria products.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4657", "label" : {"_value" : "Biography information for Anneliese Dodds"}
}
, "answeringMemberConstituency" : {"_value" : "Oxford East"}
, "answeringMemberPrinted" : {"_value" : "Anneliese Dodds"}
, "dateOfAnswer" : {"_value" : "2024-10-30", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2024-10-30T10:55:49.783Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "208"}
, "answeringDeptShortName" : {"_value" : "Foreign, Commonwealth and Development Office"}
, "answeringDeptSortName" : {"_value" : "Foreign, Commonwealth and Development Office"}
, "date" : {"_value" : "2024-10-22", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Malaria: Disease Control"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Foreign, Commonwealth and Development Affairs, what steps his Department is taking to support (a) the Global Fund, (b) Gavi, the Vaccine Alliance and (c) other multilateral organisations to eliminate malaria.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4131", "label" : {"_value" : "Biography information for Jim Shannon"}
}
, "tablingMemberConstituency" : {"_value" : "Strangford"}
, "tablingMemberPrinted" : [{"_value" : "Jim Shannon"}
], "uin" : "10446"}
, {"_about" : "http://data.parliament.uk/resources/1736113", "AnsweringBody" : [{"_value" : "Foreign, Commonwealth and Development Office"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1736113/answer", "answerText" : {"_value" : " British science was key to the development of the first two vaccines ever to be recommended for use by WHO to prevent malaria. The UK's £1.65 billion funding to Gavi is also helping to fund the rollout of malaria vaccines and will immunise more than 6 million children by the end of 2025. Our funding to the Medicines for Malaria Venture (MMV), in partnership with more than 40 UK organisations including GSK and the University of Dundee, is developing a new generation of antimalarial medicines to address the emerging threat posed by drug resistance.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4657", "label" : {"_value" : "Biography information for Anneliese Dodds"}
}
, "answeringMemberConstituency" : {"_value" : "Oxford East"}
, "answeringMemberPrinted" : {"_value" : "Anneliese Dodds"}
, "dateOfAnswer" : {"_value" : "2024-10-30", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2024-10-30T10:53:26.5Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "208"}
, "answeringDeptShortName" : {"_value" : "Foreign, Commonwealth and Development Office"}
, "answeringDeptSortName" : {"_value" : "Foreign, Commonwealth and Development Office"}
, "date" : {"_value" : "2024-10-22", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Malaria: Disease Control"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Foreign, Commonwealth and Development Affairs, what steps his Department is taking to support the rollout of new medicines developed in the UK to tackle malaria.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4131", "label" : {"_value" : "Biography information for Jim Shannon"}
}
, "tablingMemberConstituency" : {"_value" : "Strangford"}
, "tablingMemberPrinted" : [{"_value" : "Jim Shannon"}
], "uin" : "10447"}
, {"_about" : "http://data.parliament.uk/resources/1736114", "AnsweringBody" : [{"_value" : "Department for Science, Innovation and Technology"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1736114/answer", "answerText" : {"_value" : " UK Research and Innovation\u2019s Medical Research Council (MRC) supports the development of anti-malaria drugs through its Research Boards, Translation portfolio, and participation in the European and Developing Countries Clinical Trials Partnership.<\/p> The MRC contribution for active projects totals £10.93m, including £3.84m for academic-led translational projects. For instance, the University of Liverpool, in collaboration with the Medicines for Malaria Venture, has been awarded £1.12m to lead on a multinational, interdisciplinary programme to develop a drug capable of curing malaria in a single or three daily doses treatment regime.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4822", "label" : {"_value" : "Biography information for Feryal Clark"}
}
, "answeringMemberConstituency" : {"_value" : "Enfield North"}
, "answeringMemberPrinted" : {"_value" : "Feryal Clark"}
, "dateOfAnswer" : {"_value" : "2024-10-30", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2024-10-30T15:31:39.82Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "216"}
, "answeringDeptShortName" : {"_value" : "Science, Innovation and Technology"}
, "answeringDeptSortName" : {"_value" : "Science, Innovation and Technology"}
, "date" : {"_value" : "2024-10-22", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Malaria: Drugs"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Science, Innovation and Technology, what steps his Department is taking to support the life sciences sector to develop new drugs to tackle malaria.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4131", "label" : {"_value" : "Biography information for Jim Shannon"}
}
, "tablingMemberConstituency" : {"_value" : "Strangford"}
, "tablingMemberPrinted" : [{"_value" : "Jim Shannon"}
], "uin" : "10448"}
], "itemsPerPage" : 10, "next" : "https://eldaddp.azurewebsites.net/answeredquestions.text?_page=1&humanIndexable=true&tablingMemberConstituency=Strangford&min-AnswerDate=2023-09-18", "page" : 0, "startIndex" : 1, "totalResults" : 700, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]}
}